HBK Master Fund LP - Form 8.3 - Warner Chilcott Plc PR Newswire London, July 31 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER...
HBK Master Fund LP - Form 8.3 - Warner Chilcott Plc PR Newswire London, July 30 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER...
HBK Master Fund LP - Form 8.3 - Warner Chilcott Plc PR Newswire London, July 29 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER...
ARDEE, Ireland, Dec. 15 /PRNewswire-FirstCall/ -- Warner Chilcott plc (NASDAQ:WCRX) today announced that its subsidiary Warner Chilcott Corporation (the "Company") has commenced a cash tender...
ARDEE, Ireland, Nov. 19 /PRNewswire/ -- Warner Chilcott plc (NASDAQ:WCRX) today announced the pricing of its previously announced secondary offering of 20,000,000 of its ordinary shares at a...
ARDEE, Ireland, Oct. 30 /PRNewswire-FirstCall/ -- Warner Chilcott plc (NASDAQ:WCRX) announced today it has completed the acquisition of The Procter & Gamble Company's global branded prescription...
ARDEE, Ireland and COPENHAGEN, Sept. 23 /PRNewswire-FirstCall/ -- Warner Chilcott plc (NASDAQ:WCRX) and LEO Pharma announced today that, in exchange for a one-time cash payment of $1.0 billion...
ARDEE, Ireland, Aug. 21 /PRNewswire-FirstCall/ -- Warner Chilcott (NASDAQ: WCRX) announced today that its redomestication has been completed and the ultimate public holding company of the Warner...
Growth of DORYX, LOESTRIN 24 FE and ESTRACE CREAM drives solid earnings growth ARDEE, Ireland, Aug. 7 /PRNewswire-Firstcall/ -- Warner Chilcott Limited (NASDAQ:WCRX) today announced its results...
ARDEE, Ireland, Aug. 5 /PRNewswire-FirstCall/ -- Warner Chilcott Limited (NASDAQ:WCRX) announced today that at a special court-ordered meeting of shareholders held earlier today (the "Special...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales